The impact of insulin pump therapy on glycaemic profile of patients with type 2 diabetes: data from the OpT2mise study

被引：0
|
作者：
Conget, I. [1 ,2 ]
Cohen, O. [3 ]
Aronson, R. [4 ]
Castaneda, J. [5 ]
Re, R. [5 ]
Shin, J. [5 ]
Reznik, Y. [6 ]
机构：
[1] Hosp Clin Barcelona, Dept Endocrinol, Diabet Unit, Barcelona, Spain
[2] Univ Barcelona, Barcelona, Spain
[3] Ch Sheba Med Ctr, Inst Endocrinol, Tel Hashomer, Israel
[4] LMC Diabet & Endocrinol, Toronto, ON, Canada
[5] Medtronic, Northridge, CA USA
[6] Ctr Hosp Reg Univ Caen Cote de Nacre, Dept Endocrinol & Diabet, Caen, France
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1012
引用
收藏
页码：S416 / S416
页数：1
相关论文
共 50 条
  • [41] Insulin Pump Therapy in Patients with Diabetes Mellitus Type 2: A Survey of Patient Expectations
    Aberer, Felix
    Poettler, Tina
    Sourij, Harald
    Tripolt, Norbert
    Becvar, Sebastian
    Leitgeb, Silvia
    Pieber, Thomas
    Novak, Eva
    Mader, Julia K.
    DIABETES, 2017, 66 : A622 - A622
  • [42] Analysis of continuous patient data from the Czech National Register of patients with type 1 and type 2 diabetes using insulin pump therapy
    Jankovec, Z.
    Hahn, M.
    Grunder, S.
    Lacigova, S.
    Cechurova, D.
    Krcma, M.
    Zourek, M.
    Haladova, I.
    Rusavy, Z.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 87 (02) : 219 - 223
  • [43] Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study
    Jones, Stephen
    Benroubi, Marian
    Castell, Conxa
    Goday, Albert
    Liebl, Andreas
    Timlin, Louise
    Nicolay, Claudia
    Simpson, Alexander
    Tynan, Aodan
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) : 691 - 700
  • [44] Switching from insulin to dulaglutide therapy in patients with type 2 diabetes: A real-world data study
    Lee, Jiwoo
    Kim, Hwi Seung
    Jung, Chang Hee
    Park, Joong-Yeol
    Lee, Woo Je
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (08)
  • [45] Long-term glycaemic remission of type 2 diabetes mellitus with insulin pump therapy regardless of disease duration
    Choi, S.
    Hong, E.
    Jeon, E.
    Kim, K.
    An, H.
    Noh, Y.
    DIABETOLOGIA, 2015, 58 : S442 - S442
  • [46] Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy
    Berhanu, P.
    Perez, A.
    Yu, S.
    DIABETES OBESITY & METABOLISM, 2007, 9 (04): : 512 - 520
  • [47] Glycaemic control changes after the programme of personalised support for the patients with type 2 diabetes on insulin therapy
    Mayorov, A. Y.
    Melnikova, O. G.
    Surkova, E. V.
    Motovilin, O. G.
    DIABETOLOGIA, 2017, 60 : S349 - S350
  • [48] Insulin pump therapy in type 2 diabetes [Insulinpumpentherapie bei Typ-2-Diabetes]
    Pavlicek V.
    Der Diabetologe, 2014, 10 (6): : 494 - 496
  • [49] The contribution of metformin to glycaemic control in patients with Type 2 diabetes mellitus receiving combination therapy with insulin
    Tong, PC
    Chow, CC
    Jorgensen, LN
    Cockram, CS
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 57 (02) : 93 - 98
  • [50] Insulin pump therapy in patients with type 1 diabetes
    Minicucci, Walter Jose
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2008, 52 (02) : 340 - 348
12345